Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

How Do Gay Serodiscordant Couples in Sydney, Australia Negotiate Undetectable Viral Load for HIV Prevention?

Philpot SP, Prestage G, Ellard J, Grulich AE, Bavinton BR; Opposites Attract study group.

AIDS Behav. 2018 Aug 13. doi: 10.1007/s10461-018-2247-6. [Epub ahead of print]

PMID:
30105588
2.

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK, Moore R, Roth N, Bloch M, Pell C, McNulty AM, Baker D, Hoy J, Tee BK, Templeton DJ, Cooper DA, Emery S, Kelleher A, Grulich AE; Opposites Attract Study Group.

Lancet HIV. 2018 Aug;5(8):e438-e447. doi: 10.1016/S2352-3018(18)30132-2. Epub 2018 Jul 17.

PMID:
30025681
3.

Human Papillomavirus Seroprevalence and Association with Anal HPV Infection and Squamous Intraepithelial Lesions in Australian Gay and Bisexual Men.

Poynten IM, Waterboer T, Jin F, Templeton DJ, Hillman RJ, Law C, Cornall A, Tabrizi S, Roberts JM, Garland SM, Fairley CK, Grulich AE.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):768-775. doi: 10.1158/1055-9965.EPI-17-0694. Epub 2018 Apr 26.

PMID:
29700009
4.

The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets.

Keen P, Gray RT, Telfer B, Guy R, Schmidt HM, Whittaker B, Holden J, Holt M, Kelleher A, Wilson D, Callander D, Cooper DA, Prestage G, Selvey C, Grulich AE; NSW HIV Prevention Partnership Project.

J Int AIDS Soc. 2018 Apr;21(4):e25109. doi: 10.1002/jia2.25109.

5.

Correction: expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in new South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.

Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, Cooper DA, Grulich AE; EPIC-NSW study group.

BMC Public Health. 2018 Feb 28;18(1):297. doi: 10.1186/s12889-018-5173-7.

6.

Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.

Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, Cooper DA, Grulich AE; EPIC-NSW study group.

BMC Public Health. 2018 Feb 2;18(1):210. doi: 10.1186/s12889-017-5018-9. Erratum in: BMC Public Health. 2018 Feb 28;18(1):297.

7.

Risk factors for oropharyngeal gonorrhoea in men who have sex with men: an age-matched case-control study.

Cornelisse VJ, Walker S, Phillips T, Hocking JS, Bradshaw CS, Lewis DA, Prestage GP, Grulich AE, Fairley CK, Chow EPF.

Sex Transm Infect. 2018 Aug;94(5):359-364. doi: 10.1136/sextrans-2017-053381. Epub 2018 Jan 22.

PMID:
29358525
8.

Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project.

Vaccher SJ, Gianacas C, Templeton DJ, Poynten IM, Haire BG, Ooi C, Foster R, McNulty A, Grulich AE, Zablotska IB; PRELUDE Study Team.

Front Public Health. 2017 Dec 15;5:341. doi: 10.3389/fpubh.2017.00341. eCollection 2017.

9.

Learning about HIV the hard way: HIV among Chinese MSM attending university.

Zou H, Tucker JD, Fan S, Xu J, Yu M, Luo Z, Cai W, Grulich AE.

Lancet Infect Dis. 2018 Jan;18(1):16-18. doi: 10.1016/S1473-3099(17)30711-9. Epub 2017 Dec 20. No abstract available.

PMID:
29303730
10.

Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics.

Jamil MS, McManus H, Callander D, Prestage G, Ali H, O'Connor CC, Chen M, McNulty AM, Knight V, Duck T, Keen P, Gray J, Medland N, Hellard M, Lewis DA, Grulich AE, Kaldor JM, Fairley CK, Donovan B, Guy RJ; ACCESS and NSW Partnership Project Steering Committees.

AIDS Behav. 2018 Feb;22(2):513-521. doi: 10.1007/s10461-017-2012-2.

PMID:
29260354
11.

Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men.

Machalek DA, Jin F, Poynten IM, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE; SPANC study team.

Papillomavirus Res. 2016 Dec;2:97-105. doi: 10.1016/j.pvr.2016.05.003. Epub 2016 May 24.

12.

Histological outcomes of anal high-grade cytopredictions.

Roberts JM, Jin F, Poynten IM, Law C, Templeton DJ, Thurloe JK, Garland SM, Grulich AE, Farnsworth A, Hillman RJ; Study of the Prevention of Anal Cancer Study Team.

Cancer Cytopathol. 2018 Feb;126(2):136-144. doi: 10.1002/cncy.21936. Epub 2017 Oct 20.

PMID:
29053225
13.

Validation of participant eligibility for pre-exposure prophylaxis: Baseline data from the PRELUDE demonstration project.

Vaccher SJ, Grulich AE, Haire BG, Conway DP, Poynten IM, Ooi C, Foster R, Templeton DJ, Zablotska IB; PRELUDE Study Team.

PLoS One. 2017 Sep 26;12(9):e0185398. doi: 10.1371/journal.pone.0185398. eCollection 2017.

14.

Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men.

Poynten IM, Tabrizi SN, Jin F, Templeton DJ, Machalek DA, Cornall A, Phillips S, Fairley CK, Garland SM, Law C, Carr A, Hillman RJ, Grulich AE; SPANC Study Team.

Papillomavirus Res. 2017 Jun;3:80-84. doi: 10.1016/j.pvr.2017.02.003. Epub 2017 Feb 21.

15.

A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol.

Chow EPF, Walker S, Hocking JS, Bradshaw CS, Chen MY, Tabrizi SN, Howden BP, Law MG, Maddaford K, Read TRH, Lewis DA, Whiley DM, Zhang L, Grulich AE, Kaldor JM, Cornelisse VJ, Phillips S, Donovan B, McNulty AM, Templeton DJ, Roth N, Moore R, Fairley CK.

BMC Infect Dis. 2017 Jun 28;17(1):456. doi: 10.1186/s12879-017-2541-3.

16.

How partnership type and HIV seroconcordance affect HIV transmission risk in regular sexual partnerships: a cross-sectional survey of Australian gay and bisexual men.

Bavinton BR, Grulich AE, Duncan D, Zablotska IB, Prestage GP.

Sex Health. 2017 Nov;14(6):523-532. doi: 10.1071/SH16198.

PMID:
28637581
17.

Experience and psychological impact of anal cancer screening in gay, bisexual and other men who have sex with men: a qualitative study.

Russo S, Mccaffery K, Ellard J, Poynten M, Prestage G, Templeton DJ, Hillman R, Law C, Grulich AE.

Psychooncology. 2018 Jan;27(1):125-131. doi: 10.1002/pon.4480. Epub 2017 Jul 24.

PMID:
28635044
18.

Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: baseline findings from the Study of the Prevention of Anal Cancer (SPANC).

Templeton DJ, Roberts JM, Poynten IM, Law C, Hillman RJ, Farnsworth A, Fairley CK, Tabrizi SN, Garland SM, Grulich AE, Jin F; SPANC Study Team.

Eur J Cancer Prev. 2017 May;26(3):212-216. doi: 10.1097/CEJ.0000000000000321.

PMID:
28350724
19.

The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.

Jin F, Roberts JM, Grulich AE, Poynten IM, Machalek DA, Cornall A, Phillips S, Ekman D, McDonald RL, Hillman RJ, Templeton DJ, Farnsworth A, Garland SM, Fairley CK, Tabrizi SN; SPANC Research Team.

AIDS. 2017 Jun 1;31(9):1303-1311. doi: 10.1097/QAD.0000000000001462.

PMID:
28323757
20.

Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial.

Jamil MS, Prestage G, Fairley CK, Grulich AE, Smith KS, Chen M, Holt M, McNulty AM, Bavinton BR, Conway DP, Wand H, Keen P, Bradley J, Kolstee J, Batrouney C, Russell D, Law M, Kaldor JM, Guy RJ.

Lancet HIV. 2017 Jun;4(6):e241-e250. doi: 10.1016/S2352-3018(17)30023-1. Epub 2017 Feb 17.

PMID:
28219619
21.

HIV testing self-efficacy is associated with higher HIV testing frequency and perceived likelihood to self-test among gay and bisexual men.

Jamil MS, Guy RJ, Bavinton BR, Fairley CK, Grulich AE, Holt M, Smith KS, Chen M, McNulty AM, Conway DP, Keen P, Bradley J, Russell D, Kaldor JM, Prestage G; FORTH Investigator Group.

Sex Health. 2017 Apr;14(2):170-178. doi: 10.1071/SH16100.

PMID:
27883311
22.

Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.

Moore CL, Grulich AE, Prestage G, Gidding HF, Jin F, Petoumenos K, Zablotska IB, Poynten IM, Mao L, Law MG, Amin J.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):589-597.

23.

PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers.

Zablotska I, Grulich AE, Phanuphak N, Anand T, Janyam S, Poonkasetwattana M, Baggaley R, van Griensven F, Lo YR.

J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21119. doi: 10.7448/IAS.19.7.21119. eCollection 2016.

24.

Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review.

Jin F, Matthews GV, Grulich AE.

Sex Health. 2017 Feb;14(1):28-41. doi: 10.1071/SH16141.

PMID:
27712618
25.

Differences Between Landline and Mobile Phone Users in Sexual Behavior Research.

Badcock PB, Patrick K, Smith AMA, Simpson JM, Pennay D, Rissel CE, de Visser RO, Grulich AE, Richters J.

Arch Sex Behav. 2017 Aug;46(6):1711-1721. doi: 10.1007/s10508-016-0859-3. Epub 2016 Sep 26.

PMID:
27671783
26.

CpG Methylation Analysis of HPV16 in Laser Capture Microdissected Archival Tissue and Whole Tissue Sections from High Grade Anal Squamous Intraepithelial Lesions: A Potential Disease Biomarker.

Molano M, Tabrizi SN, Garland SM, Roberts JM, Machalek DA, Phillips S, Chandler D, Hillman RJ, Grulich AE, Jin F, Poynten IM, Templeton DJ, Cornall AM; SPANC Study Team.

PLoS One. 2016 Aug 16;11(8):e0160673. doi: 10.1371/journal.pone.0160673. eCollection 2016.

27.

A Composite Cytology-Histology Endpoint Allows a More Accurate Estimate of Anal High-Grade Squamous Intraepithelial Lesion Prevalence.

Machalek DA, Poynten IM, Jin F, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE; SPANC study team.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1134-43. doi: 10.1158/1055-9965.EPI-15-1106. Epub 2016 Apr 27.

28.

The value of a transformation zone component in anal cytology to detect HSIL.

Roberts JM, Jin F, Thurloe JK, Ekman D, Adams MK, McDonald RL, Biro C, Poynten IM, Grulich AE, Farnsworth A; Study of the Prevention of Anal Cancer (SPANC) Study Team.

Cancer Cytopathol. 2016 Aug;124(8):596-601. doi: 10.1002/cncy.21730. Epub 2016 May 13.

29.

Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.

Na R, Laaksonen MA, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Br J Haematol. 2016 Aug;174(4):550-62. doi: 10.1111/bjh.14083. Epub 2016 May 2.

PMID:
27136044
30.

Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men.

Zou H, Tabrizi SN, Grulich AE, Hocking JS, Garland SM, Bradshaw CS, Cornall AM, Fairley CK, Chen MY.

Int J Cancer. 2016 Aug 1;139(3):639-46. doi: 10.1002/ijc.30093. Epub 2016 Apr 4.

31.

The Meaning of 'Regular Partner' in HIV Research Among Gay and Bisexual Men: Implications of an Australian Cross-Sectional Survey.

Bavinton BR, Duncan D, Grierson J, Zablotska IB, Down IA, Grulich AE, Prestage GP.

AIDS Behav. 2016 Aug;20(8):1777-84. doi: 10.1007/s10461-016-1354-5.

PMID:
26971284
32.

The performance of anal cytology as a screening test for anal HSILs in homosexual men.

Jin F, Grulich AE, Poynten IM, Hillman RJ, Templeton DJ, Law CL, Farnsworth A, Garland SM, Fairley CK, Roberts JM; SPANC Study Team.

Cancer Cytopathol. 2016 Jun;124(6):415-24. doi: 10.1002/cncy.21702. Epub 2016 Feb 24.

33.

Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men.

Moore CL, Gidding HF, Jin F, Mao L, Petoumenos K, Zablotska IB, Poynten IM, Prestage G, Law MG, Grulich AE, Amin J.

AIDS Behav. 2016 Oct;20(10):2372-2386. doi: 10.1007/s10461-016-1303-3.

34.

High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study.

Na R, Laaksonen MA, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

J Am Acad Dermatol. 2016 Jun;74(6):1144-1152.e6. doi: 10.1016/j.jaad.2015.12.044. Epub 2016 Jan 30.

PMID:
26830865
35.

Willingness to Act upon Beliefs about 'Treatment as Prevention' among Australian Gay and Bisexual Men.

Bavinton BR, Holt M, Grulich AE, Brown G, Zablotska IB, Prestage GP.

PLoS One. 2016 Jan 7;11(1):e0145847. doi: 10.1371/journal.pone.0145847. eCollection 2016.

36.

Rationale and design of FORTH: a randomised controlled trial assessing the effectiveness of HIV self-testing in increasing HIV testing frequency among gay and bisexual men.

Jamil MS, Prestage G, Fairley CK, Smith KS, Kaldor JM, Grulich AE, McNulty AM, Chen M, Holt M, Conway DP, Wand H, Keen P, Batrouney C, Bradley J, Bavinton BR, Ryan D, Russell D, Guy RJ.

BMC Infect Dis. 2015 Dec 10;15:561. doi: 10.1186/s12879-015-1300-6.

37.

Papillary Immature Metaplasia of the Anal Canal: A Low-grade Lesion That Can Mimic a High-grade Lesion.

Roberts JM, Cornall AM, Ekman D, Law C, Poynten IM, Jin F, Hillman RJ, Templeton DJ, Tabrizi SN, Garland SM, Thurloe JK, Grulich AE, Farnsworth A.

Am J Surg Pathol. 2016 Mar;40(3):348-53. doi: 10.1097/PAS.0000000000000549.

PMID:
26551619
38.

Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men.

Moore CL, Grulich AE, Prestage G, Gidding HF, Jin F, Mao L, Petoumenos K, Zablotska IB, Poynten IM, Law MG, Amin J.

HIV Med. 2016 May;17(5):327-39. doi: 10.1111/hiv.12312. Epub 2015 Sep 6.

39.

Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions.

Cornall AM, Roberts JM, Molano M, Machalek DA, Phillips S, Hillman RJ, Grulich AE, Jin F, Poynten IM, Templeton DJ, Garland SM, Tabrizi SN; SPANC Study Team.

BMJ Open. 2015 Aug 26;5(8):e008439. doi: 10.1136/bmjopen-2015-008439.

40.

Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.

Na R, Laaksonen MA, Grulich AE, Webster AC, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Clin Transplant. 2015 Nov;29(11):978-90. doi: 10.1111/ctr.12617. Epub 2015 Sep 24.

PMID:
26278925
41.

Homosexual men in HIV serodiscordant relationships: implications for HIV treatment as prevention research.

Bavinton BR, Jin F, Mao L, Zablotska I, Prestage GP, Grulich AE.

J Int AIDS Soc. 2015 May 25;18:19884. doi: 10.7448/IAS.18.1.19884. eCollection 2015.

42.

High reproducibility of histological diagnosis of human papillomavirus-related intraepithelial lesions of the anal canal.

Roberts JM, Jin F, Thurloe JK, Biro C, Poynten IM, Tabrizi SN, Fairley CK, Templeton DJ, Carr AD, Garland SM, Hillman RJ, Cornall AM, Grulich AE, Farnsworth A.

Pathology. 2015 Jun;47(4):308-13. doi: 10.1097/PAT.0000000000000246.

PMID:
25938361
43.

The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study.

Vajdic CM, Marashi Pour S, Olivier J, Swart A, O'Connell DL, Falster MO, Meagher NS, Mao L, Grulich AE, Randall DA, Amin J, Burns L, Degenhardt L.

Drug Alcohol Depend. 2015 Jul 1;152:264-71. doi: 10.1016/j.drugalcdep.2015.03.026. Epub 2015 Apr 6. Erratum in: Drug Alcohol Depend. 2015 Sep 1;154:304. Pour, Sadaf Marashi [corrected to Marashi Pour, Sadaf].

PMID:
25936861
44.

The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation.

Grulich AE, Vajdic CM.

Semin Oncol. 2015 Apr;42(2):247-57. doi: 10.1053/j.seminoncol.2014.12.029. Epub 2014 Dec 31. Review.

PMID:
25843729
45.

"Any Condomless Anal Intercourse" is No Longer an Accurate Measure of HIV Sexual risk Behavior in Gay and Other Men Who have Sex with Men.

Jin F, Prestage GP, Mao L, Poynten IM, Templeton DJ, Grulich AE, Zablotska I.

Front Immunol. 2015 Feb 27;6:86. doi: 10.3389/fimmu.2015.00086. eCollection 2015.

46.

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Rodger AJ, Lampe FC, Grulich AE, Fisher M, Friedland G, Phanuphak N, Bogner JR, Pereira LC, Rietmeijer C, Burman W, Phillips AN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:64-76. doi: 10.1111/hiv.12235.

47.

Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.

Zou H, Tabrizi SN, Grulich AE, Hocking JS, Bradshaw CS, Cornall AM, Morrow A, Prestage G, Law MG, Garland SM, Chen MY, Fairley CK.

Lancet Infect Dis. 2015 Jan;15(1):65-73. doi: 10.1016/S1473-3099(14)70994-6. Epub 2014 Nov 28.

PMID:
25435055
48.

Change and stasis in sexual health and relationships: comparisons between the First and Second Australian Studies of Health and Relationships.

de Visser RO, Richters J, Rissel C, Badcock PB, Simpson JM, Smith AM, Grulich AE.

Sex Health. 2014 Nov;11(5):505-9. doi: 10.1071/SH14112. No abstract available.

PMID:
25377003
49.

Safer sex and condom use: findings from the Second Australian Study of Health and Relationships.

de Visser RO, Badcock PB, Rissel C, Richters J, Smith AM, Grulich AE, Simpson JM.

Sex Health. 2014 Nov;11(5):495-504. doi: 10.1071/SH14102.

PMID:
25377002
50.

Knowledge about and experience of sexually transmissible infections in a representative sample of adults: the Second Australian Study of Health and Relationships.

Grulich AE, de Visser RO, Badcock PB, Smith AM, Richters J, Rissel C, Simpson JM.

Sex Health. 2014 Nov;11(5):481-94. doi: 10.1071/SH14121.

PMID:
25377001

Supplemental Content

Loading ...
Support Center